EndoGI Medical Overview
EndoGI Medical is a medical device company developing a multiple stent placement delivery system for the treatment of biliary and pancreatic duct stenosis and strictures caused by cancer, injury, inflammation, cholangitis, or gallstones. The EndoGI system enables the insertion and placement of two or more plastic stents in the common bile or hepatic ducts with one passage of the delivery system while securing and maintaining access using a guide wire at the targeted anatomical site. In July 2020, EndoGI Medical received FDA approval for its technology, which enables the possibility of inserting two stents simultaneously into the bile ducts connected to the pancreas, significantly reducing the danger of exposing patients to infections and other life-threatening situations caused by the repetitive insertions of singular stents. Following the FDA approval, the company is focusing on receiving approval from the Israeli Health Ministry and marketing the technology for clinical use in Israel and the United States.
Cumulative Funding Raised Over Time ($)
Latest News
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $54.68K |
| Last funding | Undisclosed |
| Stage | A |
| Rounds | 3 |
| Investors | 2 |
Team Members
4
Employees: 1-10
Web & Social Links
| Website | www.endo-gi.com/ |
Locations
Wadi el-Haj Street 13, Nazareth, Israel
Photos & Videos
1 item(s)
